Sort
82,697 grants matching “vaccine development”
Antibody mediated protective immunity against cholera
$725,518Jason B Harris · Massachusetts General Hospital · R01 · FY2022 · AI
Universal Influenza Vaccines (UIV)
$725,497Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Modulation of Human Cells by Virulent Francisella tularensis
$725,489Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Genetics of Coxiella burnetii
$725,486Robert A Heinzen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Natural killer cell regulation of the germinal center HIV neutralizing antibody response
$725,421Todd Christopher Bradley · Children'S Mercy Hosp (Kansas City, Mo) · R56 · FY2019 · AI
Immunologic Signatures of SARS-CoV-2 Vaccination and Disease
$725,409Dan H. Barouch · Beth Israel Deaconess Medical Center · U01 · FY2022 · CA
Maternal Antibody-Mediated Enhancement of Dengue Pathogenesis
$725,399Sujan Shresta · La Jolla Institute For Immunology · R01 · FY2022 · AI
Maternal Antibody-Mediated Enhancement of Dengue Pathogenesis
$725,399Sujan Shresta · La Jolla Institute For Immunology · R01 · FY2021 · AI
Vaccines and Therapeutics for Anthrax
$725,395Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
$725,395Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2020 · AI
Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy
$725,288Pamela Tinmoi Wong · University Of Michigan At Ann Arbor · R01 · FY2023 · AI
Structural and functional basis of ultra potent CHKV neutralization by human mAbs
$725,215James E Crowe · Vanderbilt University Medical Center · R01 · FY2018 · AI
ENTAMOEBA HISTOLYTICA GENOME PROJECT
$725,176Institute For Genomic Research · R01 · FY2002 · AI
Integrated Platform for the Discovery of Antibacterial
$725,136Suzanne L. Walker · Harvard Medical School · U19 · FY2014 · AI
Genetic Markers of Long-Term Mumps Vaccine Immunity
$725,120Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2018 · AI
Multi-Omics Characterization of Plasmodium Vivax Hypnozoites
$725,059David Serre · University Of Maryland Baltimore · R01 · FY2023 · AI
Molecular-Targeted Radiation Therapy
$725,049C Norman Coleman · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$724,994David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Enviromental Factors in the Etiology of Autism
$724,940University Of California Davis · P01 · FY2005 · ES
Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure
$724,871Christina Louise Lancioni · Oregon Health & Science University · R01 · FY2025 · AI
Molecular Genetic Analysis of Mycobacterium tuberculosis
$724,867William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2014 · AI
EpiMoRPH: A simulation environment for generating spatially-refined intervention strategies for the control of infectious disease
$724,855Joseph Mihaljevic · Northern Arizona University · R01 · FY2022 · AI
Immune correlates of tuberculosis and non-tuberculosis infectious morbidity in Southern African HIV-exposed, uninfected infants.
$724,699Kathleen Powis · Massachusetts General Hospital · R01 · FY2019 · AI
Mechanisms of effective antibody neutralization
$724,692Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Structural characterization of host-pathogen interactions
$724,692Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI